This real-world study, conducted between September and December 2024, also showed that the impact of symptoms on daily activities, including work and family responsibilities, was lower in recipients ...
The MarketWatch News Department was not involved in the creation of this content. -- Preliminary data showed Novavax's non-mRNA JN.1 COVID-19 vaccine induced lower frequency and severity of short-term ...
May 19, 2025 – The FDA has approved the Novavax COVID-19 vaccine, a protein-based alternative to mRNA shots, with some limits on who can get it. The vaccine, called Nuvaxovid, is mainly intended for ...
US regulators grant full approval to Novavax shot but sharply limit eligibility. New studies on heart risks required, raising concerns over future vaccine access. The US Food and Drug Administration ...
Approval had been delayed since April 1 Company said received OK after substantial back and forth Will need additional approval to change strain of vaccine May 17 (Reuters) - The U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results